HR 174·LA·house
DRUGS/TESTING: Requests the state surgeon general and the Louisiana Department of Health to assess the feasibility of advancing fenbendazole or similar treatments for potential human use in cancer treatment and to provide guidance on engaging federal authorities for expedited evaluation while protecting public health
Passed Both ChambersFiled Apr 20, 2026
Sponsor: Chuck Owen (R)
Latest Action
Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
May 21, 2026
Summary
The measure asks the state surgeon general and the Louisiana Department of Health to evaluate whether fenbendazole or similar drugs could be moved toward human cancer treatment. It also requires them to give guidance on working with federal agencies to speed up any evaluation while safeguarding public health. The bill aims to explore a potential new therapy for cancer patients.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 174 changes status, plus AI-powered summaries and stage predictions.
Sign up free